Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19 : a randomized clinical trial
| izdano v: | Nature Cancer 4(2023)1, S. 96-107 |
|---|---|
| VerfasserIn: | , , , |
| Format: | Aufsatz in Zeitschrift |
| Jezik: | English |
| Izdano: |
2023
|
| Teme: | |
| Online dostop: | https://doi.org/10.1038/s43018-022-00503-w |
| Sorodne knjige/članki: | In:
Nature Cancer |
| Opis knjige/članka: | Exemplar/Standort: Open Access |
|---|---|
| DOI: | 10.1038/s43018-022-00503-w |
| Signatura: | Open Access |